There has been back-and-forth among experts on the relationship between breast arterial calcifications and cardiovascular disease for many years.

The organization is deploying the LumiSystem, which uses fluorescent dye and a small scope to illuminate cancerous tissue in the breast cavity during lumpectomy surgery.

This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy. 

New research may help providers identify patterns on neuroimaging that could offer clues into how well patients are responding to antidepressant medications.

Many have touted smoking marijuana as a safer alternative to cigarettes. New imaging data offer clarity on whether this notion is actually true. 

Overpromising AI capabilities to hospital stakeholders—now there’s a mistake healthcare AI enthusiasts have been known to make.

Attorneys are targeting Northwest Radiologists and the related Mount Baker Imaging, who allegedly failed to protect patient info before a January data breach. 

The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients. 

In a new report, the AHA said strains from President Trump’s tariffs and struggles with Medicare Advantage plans are creating “financial headwinds” that could shake the economic stability of hospitals nationwide.